Work

Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists

Year: 2025

Type: article

Abstract: This cross-sectional study examines Medicare Part D coverage and out-of-pocket costs for glucagon-like peptide-1 receptor agonists following implementation of the Inflation Reduction Act.

Source: JAMA

DOI: 10.1001/jama.2025.15841

Authors: Matthew J. Klebanoff, Pengxiang Li, Judith A. Long, Jalpa A. Doshi

Institutions: Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia VA Medical Center

Language: English

Topic: Healthcare Policy and Management

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4414466446

FWCI: 11.51

Cites: 4

Cited by: 12

Related to: